{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:20:19Z","timestamp":1788236419950,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":549,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.exphem.2024.104696","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T15:51:13Z","timestamp":1734364273000},"page":"104696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The inhibitory receptor PVRIG is dominantly expressed in the bone marrow of patients with multiple myeloma and its blockade enhances T-cell engager's immune activation"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1034-2140","authenticated-orcid":false,"given":"Masha","family":"Frenkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0687-0456","authenticated-orcid":false,"given":"Zoya","family":"Alteber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1547-5190","authenticated-orcid":false,"given":"Deborah","family":"Hayoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6487-2559","authenticated-orcid":false,"given":"Roy Zvi","family":"Granit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gady","family":"Cojocaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1587-6104","authenticated-orcid":false,"given":"James","family":"Berenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Ophir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2024.104696_bib0001","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.exphem.2024.104696_bib0002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13045-021-01084-4","article-title":"Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies","volume":"14","author":"Tian","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2024.104696_bib0003","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1172\/JCI129205","article-title":"Immunotherapy of multiple myeloma","volume":"130","author":"Minnie","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2024.104696_bib0004","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/hon.3071","article-title":"The JAK1\/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma","volume":"41","author":"Xu","year":"2023","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.exphem.2024.104696_bib0005","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2018-01-825240","article-title":"Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade","volume":"132","author":"Minnie","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104696_bib0006","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2018-01-825265","article-title":"TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma","volume":"132","author":"Guillerey","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104696_bib0007","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clml.2023.09.002","article-title":"Efficacy and safety of immune checkpoint inhibitors in hematologic malignancies","volume":"24","author":"Bilgihan","year":"2024","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.exphem.2024.104696_bib0008","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1158\/2159-8290.CD-20-1248","article-title":"Therapeutic Targeting of Checkpoint Receptors within the DNAM1 Axis","volume":"11","author":"Alteber","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.exphem.2024.104696_bib0009","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/2326-6066.CIR-18-0442","article-title":"PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function","volume":"7","author":"Whelan","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.exphem.2024.104696_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1158\/2326-6066.CIR-18-0460","article-title":"Mouse PVRIG has CD8+ T cell-specific coinhibitory functions and dampens antitumor immunity","volume":"7","author":"Murter","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.exphem.2024.104696_bib0011","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/2326-6066.CIR-23-0752","article-title":"PVRIG is expressed on stem-like T cells in dendritic cell-rich niches in tumors and its blockade may induce immune infiltration in non-inflamed tumors","volume":"12","author":"Alteber","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.exphem.2024.104696_bib0012","doi-asserted-by":"crossref","unstructured":"Nemzer S, Sabath N, Wool A, et al. Gene model correction for PVRIG in single cell and bulk sequencing data enables accurate detection and study of its functional relevance. bioRxiv. doi:10.1101\/2022.11.02.514879.","DOI":"10.1101\/2022.11.02.514879"},{"key":"10.1016\/j.exphem.2024.104696_bib0013","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/s12276-022-00884-z","article-title":"Single-cell analysis of multiple myelomas refines the molecular features of bortezomib treatment responsiveness","volume":"54","author":"Jung","year":"2022","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.exphem.2024.104696_bib0014","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1158\/1078-0432.CCR-19-3673","article-title":"Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma","volume":"26","author":"Lozano","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2024.104696_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41420-024-01818-6","article-title":"Targeted immunotherapy: harnessing the immune system to battle multiple myeloma","volume":"10","author":"Xu","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.exphem.2024.104696_bib0016","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/2326-6066.CIR-19-0877","article-title":"CD226hiCD8+ T cells are a prerequisite for anti-TIGIT immunotherapy","volume":"8","author":"Jin","year":"2020","journal-title":"Cancer Immunol Res"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:01:25Z","timestamp":1788235285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X24005605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":16,"alternative-id":["S0301472X24005605"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104696","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inhibitory receptor PVRIG is dominantly expressed in the bone marrow of patients with multiple myeloma and its blockade enhances T-cell engager's immune activation","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104696"}}